VANCOUVER, BC, Jan. 31, 2022 /CNW/ - Willow Biosciences
Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:
CANSF), a leading biotechnology company that manufactures pure,
consistent and sustainable cannabinoids via yeast biosynthesis,
today announced that it will host a webcast investor presentation
on Thursday, February 3rd at
2:00 PM EST.
During the webcast, Willow's President and Chief Executive
Officer Trevor Peters will provide a
presentation through a PowerPoint discussion that will cover key
areas of Willow's business. After the formal presentation,
investors will have an opportunity to ask relevant questions
through an interactive Q&A portal.
To listen to the webcast or to ask questions during the live
event, please pre-register at the following link:
An archived version of the webcast and presentation will be
available on the Company's website,
About Willow Biosciences Inc.
Willow is a leading biotechnology company that develops and
produces high-purity, plant derived ingredients for the consumer
care, food and beverage, and pharmaceutical markets. Willow's
FutureGrown™ biotechnology platform allows scale
production of pure, consistent, and sustainable product to benefit
both B2B and B2C customers. Willow's R&D team has a proven
track record of developing and commercializing bio-based
manufacturing processes and products for both the consumer and
This news release may include forward-looking statements
including opinions, assumptions, estimates and the Company's
assessment of future plans and operations, and, more particularly,
statements concerning the business plan of the Company, generally,
including cannabinoid research and production. When used in this
news release, the words "will," "anticipate," "believe,"
"estimate," "expect," "intent," "may," "project," "should," and
similar expressions are intended to be among the statements that
identify forward-looking statements. The forward-looking statements
are founded on the basis of expectations and assumptions made by
the Company. Any number of important factors could cause actual
results to differ materially from those in the forward-looking
statements. Please refer to the Company's most recent annual
information form and management's discussion and analysis for l
risk factors relating to Willow, which can be accessed either on
Willow's website at www.willowbio.com or under the Company's
profile on www.sedar.com.
The forward-looking statements contained in this news release
are made as of the date hereof and the Company does not undertake
any obligation to update publicly or to revise any of the included
forward-looking statements, except as required by applicable law.
The forward-looking statements contained herein are expressly
qualified by this cautionary statement.
View original content to download
SOURCE Willow Biosciences Inc.